Davide Bedognetti

17.8k citations
134 papers · 6.2k · 3 hit papers · h-index 40

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer

Papers in

    • Cancer Immunotherapy and Biomarkers 42
    • CAR-T cell therapy research 13
    • Immunotherapy and Immune Responses 23
    • Immune Cell Function and Interaction 12

Davide Bedognetti

129 papers receiving 6.1k citations

Davide Bedognetti's Hit Papers

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments 2022 · 533 citations
5330+4+8Years since publication200400600

Peers

Davide Bedognetti
Comparison fields: 5 of 143
  • Oncology 2.3k
  • Immunology 1.7k
  • Cancer Research 876
  • Molecular Biology 1.7k
  • Biomedical Engineering 1.1k
Replace Kurt R. Zinn with:
Kurt R. Zinn United States
Yifan Wang China
Patrick Soon‐Shiong United States
Guobin Wang China
Byeong‐Cheol Ahn South Korea
Zhenfeng Duan United States
Xin Lü China
Yao Wang China
Meng Xu China
Michel Obéid Switzerland
Davide Bedognetti relative to Kurt R. Zinn United States Kurt R. Zinn's profile →
Citations per field
00.5×2.9×
Kurt R. Zinn · 1×
Citations per year

Countries citing papers authored by Davide Bedognetti

Since Specialization
Citations

This map shows the geographic impact of Davide Bedognetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Bedognetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Bedognetti more than expected).

Fields of papers citing papers by Davide Bedognetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Bedognetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Bedognetti. The network helps show where Davide Bedognetti may publish in the future.

Co-authors

The 25 scholars most cited alongside Davide Bedognetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Davide Bedognetti Line = papers co-authored together Davide Bedognetti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Hit paper breakdown →
2013627
2
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Hit paper breakdown →
2022533
3
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Hit paper breakdown →
2020454
4 2018291
5 2018286
6 2018213
7 2017130
8 2012129
9 2019123
10 2021121
11 2014110
12 2017110
13 2021107
14 2017105
15 2013104
16 2020102
17 2013100
18 201384
19 201180
20 201580

About Davide Bedognetti

Davide Bedognetti is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 134 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (42 papers), Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (13 papers), Cancer Genomics and Diagnostics (12 papers), Immune Cell Function and Interaction (12 papers), Ferroptosis and cancer prognosis (11 papers), Graphene and Nanomaterials Applications (11 papers) and Nanoplatforms for cancer theranostics (8 papers). The work is most often cited by research in Oncology (2.3k citations), Immunology (1.7k citations), Cancer Research (876 citations), Molecular Biology (1.7k citations) and Biomedical Engineering (1.1k citations). Davide Bedognetti has collaborated with scholars based in United States, Qatar and Italy. Frequent co-authors include Francesco M. Marincola, Jérôme Galon, Francesco M. Marincola, Helen K. Angell, Lucia Gemma Delogu, Wouter Hendrickx, Ena Wang, Jessica Roelands, Alberto Bianco and Mohammad Haris. Their work appears in journals such as Journal of Translational Medicine, Journal for ImmunoTherapy of Cancer, British Journal of Cancer, Frontiers in Immunology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact